FDA Approved: CINVANTI — Supplemental Application (Heron Therapeutics, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for CINVANTI (aprepitant) from Heron Therapeutics, expanding its labeling/indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• CINVANTI (aprepitant)

Snippet

SUPPL AP for CINVANTI (APREPITANT)